"Technology review needed to help UK allergy diagnosis and care", says epidemiologist:
This article was originally published in Clinica
There is an urgent need to review the technology involved in the diagnosis and monitoring of allergic conditions and their care, in light of the "dramatic increase" in prevalence of these across the western world, especially in the UK, which has one of the highest levels. So warned epidemiologist Aziz Sheikh, at his inaugural lecture as professor of primary care R&D, community health sciences, at Edinburgh University. Allergies affect some 40% of UK children and 30% of adults in the UK, and cost the NHS around £1bn ($1.8bn) per year, according to conservative estimates. He also cited the recent "scathing" House of Commons Health Select Committee's report on NHS provision of allergy services, in calling for an urgent review of these.
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.